Nyxoah discloses major shareholder holdings following IPO
Medical technology firm Nyxoah has released regulatory filings detailing its major shareholders following its initial public offering on Euronext Brussels.
Nyxoah has officially disclosed the ownership structure of its major shareholders following its listing on the Euronext Brussels exchange. The transparency notifications were issued in compliance with the Belgian Act of 2 May 2007, reflecting voting rights held as of the company's debut on September 18, 2020.
Leading the disclosed positions is Cochlear Limited, which holds 18.43% of the total voting rights through its subsidiary, Cochlear Investments Pty Ltd. Robert Taub, acting through Robelga SRL, Ronata, and MINV SA, maintains a 13.15% stake, while Together Partnership holds 11.69% of the voting power.
Jürgen Hambrecht was also listed with an ownership stake of 4.89%. These filings account for the total denominator of 21,423,859 voting rights that were established upon the company's entry into the public market.